Request Deal Involvement

Syncona and Mass General Brigham Ventures led a $56m Series B round in SwanBio Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

FTI Consulting

pr advisors

FTI Consulting

or

Principals

SWANBIO THERAPEUTICS

target

SWANBIO THERAPEUTICS

SYNCONA LTD

bidder

SYNCONA LTD

MASS GENERAL BRIGHAM VENTURES

bidder

MASS GENERAL BRIGHAM VENTURES

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite